ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $246 | -11.5% | 6,087 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $278 | -99.9% | 5,969 | -7.4% | 0.00% | 0.0% |
| Q3 2022 | $334,000 | +23.7% | 6,447 | +70.0% | 0.00% | +100.0% |
| Q1 2022 | $270,000 | +0.7% | 3,793 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $268,000 | -20.7% | 3,587 | +23.1% | 0.00% | -50.0% |
| Q2 2018 | $338,000 | +31.5% | 2,914 | -8.3% | 0.00% | 0.0% |
| Q1 2018 | $257,000 | -10.1% | 3,178 | -34.7% | 0.00% | 0.0% |
| Q4 2017 | $286,000 | +550.0% | 4,866 | +144.5% | 0.00% | – |
| Q2 2016 | $44,000 | +18.9% | 1,990 | +56.9% | 0.00% | – |
| Q1 2016 | $37,000 | +19.4% | 1,268 | +34.0% | 0.00% | – |
| Q4 2015 | $31,000 | -32.6% | 946 | -25.1% | 0.00% | – |
| Q3 2015 | $46,000 | +155.6% | 1,263 | +221.4% | 0.00% | – |
| Q2 2015 | $18,000 | +200.0% | 393 | +99.5% | 0.00% | – |
| Q1 2015 | $6,000 | -40.0% | 197 | -2.0% | 0.00% | – |
| Q4 2014 | $10,000 | +11.1% | 201 | -15.2% | 0.00% | – |
| Q3 2014 | $9,000 | -25.0% | 237 | -12.2% | 0.00% | – |
| Q2 2014 | $12,000 | +9.1% | 270 | 0.0% | 0.00% | – |
| Q1 2014 | $11,000 | +57.1% | 270 | +0.7% | 0.00% | – |
| Q4 2013 | $7,000 | – | 268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |